Similar Search Results

A comparison of the cost-effectiveness of treatment of prolonged acute convulsive epileptic seizures in children across Europe

Lee, Dawn C.; Gladwell, Daniel; Hatswell, Anthony J.; … - In: Health Economics Review 4 (2014) 6, pp. 1-15

In the majority of children and adolescents with epilepsy, optimal drug therapy adequately controls their condition. However, among the remaining patients who are still uncontrolled despite mono-, bi- or tri-therapy with chronic anti-epileptic treatment, a rescue medication is required. In...

Persistent link: https://www.econbiz.de/10011599807

The Role of decision-analytic modelling in German health technology assessments

Kuhlmann, Alexander; Treskova, Marina; Braun, Sebastian; … - In: Health Economics Review 5 (2015) 7, pp. 1-7

Background: Decision-analytic modelling (DAM) has become a widespread method in health technology assessments (HTA), but the extent to which modelling is used differs among international HTA institutions. In Germany, the use of DAM is optional within HTAs of the German Institute of Medical...

Persistent link: https://www.econbiz.de/10011599818

Leveraging EUnetHTA's conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer's point of view

Giuliani, Giovanni; Chassagnol, Frederic; Traub, David; … - In: Health Economics Review 8 (2018) 24, pp. 1-11

. We reviewed recent appraisals of a pharmaceutical manufacturer in three major European markets (France; Italy; Germany … current management of the condition (unmet need, Italy), the regulatory status (Orphan Designation, Germany), as well as … medicines was 63 (Germany), 459 (Italy), and 557 days (France). Conclusions: The clinical domains of the EUnetHTA framework are …

Persistent link: https://www.econbiz.de/10012010780

Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer

Bilekova, Beata Kiselova; Gavurova, Beata; Rogalewicz, … - In: Health Economics Review 8 (2018) 27, pp. 1-13

Background: Health technology assessment (HTA) is currently one of the major challenges in assessing medical innovations and healthcare systems. In Europe, the European Network for Health Technology Assessment (EUnetHTA) has been aspiring to develop and implement standards for international...

Persistent link: https://www.econbiz.de/10012010783

Essential notion of the health economic evaluation: Definition

Botchkarev, Alexei - In: Atlantic Review of Economics 2 (2016)

Background: Economic evaluation (EE) is a dynamically advancing knowledge area of health economics. It has been conceived to provide evidence for allocating scarce resources to gain the best value for money. The problem of efficiency of investments becomes even more crucial with advances in...

Persistent link: https://www.econbiz.de/10011966823

Setting hospital infection control policy : a decision-making framework incorporating health economics and healthcare epidemiology

Halton, Kate Amanda - 2009

Background: Reducing rates of healthcare acquired infection has been identified by the Australian Commission on Safety and Quality in Health Care as a national priority. One of the goals is the prevention of central venous catheter-related bloodstream infection (CR-BSI). At least 3,500 cases of...

Persistent link: https://www.econbiz.de/10009437871

Development and description of GETT: a Genetic testing Evidence Tracking Tool

School of Biomedical Sciences

Background: The completion of the Human Genome Project has increased the pace of discovery of genetic markers for disease. Despite tremendous efforts in fundamental research, clinical applications still lag behind expectations, partly due to the lack of effective tools to systematically search...

Persistent link: https://www.econbiz.de/10009479418

An Outcome Evaluation of the Philippine Health Technology Assessment Program

Wong, John Q.; Co, Stephanie Anne L.; Modina, Cheyenne … - 2022

The passage of the UHC law in 2019 mandated the creation of the Health Technology Assessment (HTA) Program to identify and recommend the most cost-effective health technologies for the Philippine government to procure. Since its inception, the HTA has mostly assessed COVID-19 related...

Persistent link: https://www.econbiz.de/10014485137

The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: Evidence from an online experiment

Wettstein, Dominik J.; Boes, Stefan - In: Health Economics Review 10 (2020) 13, pp. 1-15

Background: The necessity to measure and reward "value for money" of new pharmaceuticals has become central in health policy debates, as much as the requirement to assess the "willingness to pay" for an additional, qualityadjusted life year (QALY). There is a clear need to understand the...

Persistent link: https://www.econbiz.de/10014489832

How innovation can be defined, evaluated and rewarded in health technology assessment

Rejon-Parrilla, Juan Carlos; Espin, Jaime; Epstein, David - In: Health Economics Review 12 (2022) 1, pp. 1-11

relation to health technology assessment. We also describe how a selection of countries (England, France, Italy, Spain and … Italy use features such as severity, unmet need and therapeutic added value as indicators of the degree of innovation of a …

Persistent link: https://www.econbiz.de/10014489847